Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 145,369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Type 2 Diabetes Mellitus
Interventions: dutogliptin, sitagliptin; Drug
Lead sponsor: Phenomix; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 23
States / cities: Montgomery, Alabama • Tempe, Arizona • Anaheim, California + 18 more

Conditions: COVID, Covid-19, Corona Virus Infection, Coronavirus Infection, Coronavirus-19, SARS-CoV2, SARS-CoV Infection
Interventions: Ivermectin, Doxycycline Hcl, Zinc, Vitamin D3, Vitamin C; Drug · Dietary Supplement
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ventura, California

Conditions: Cervical Cancers
Interventions: 3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy; Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma
Interventions: Enterade, Placebo, Standard Supportive Care; Dietary Supplement · Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lewy Body Dementia, Parkinson Disease
Interventions: Sitagliptin, Dapagliflozin, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Blood Pressure, Vascular Function, Adherence, Treatment
Interventions: App-Based Inspiratory Muscle Strength Training, Clinic-Based Inspiratory Muscle Strength Training; Device
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Diabetes, Diabetes Mellitus, Type 2, Delivery Systems
Interventions: pump, insulin aspart; Device · Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 30 Years to 70 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 6
States / cities: Chula Vista, California • Miami, Florida • Witchita, Kansas + 3 more

Conditions: Malignancy, Immune System Diseases, Autoimmune Diseases
Interventions: Biospecimen Collection, Medical Chart Review, Questionnaires/Surveys; Procedure · Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Deep Brain Stimulation, Parkinson Disease, Apraxia, Motor
Interventions: Deep brain stimulation effect on apraxia; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Diagnostic Self Evaluation, Central Nervous System Diseases
Interventions: Dotarem (gadoterate meglumine), Magnevist (gadopentetate dimeglumine); Drug
Lead sponsor: Guerbet; Industry
Eligibility: 2 Years and older
Enrollment: 416 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 20
States / cities: Birmingham, Alabama • Tucson, Arizona • Indian Wells, California + 14 more

Conditions: Osteoarthritis, Knee
Interventions: Genicular nerve radiofrequency ablation, Pain Management Radiofrequency Kit; Procedure · Device
Lead sponsor: Millennium Pain Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 3
States / cities: Bloomington, Illinois • Decatur, Illinois • Peoria, Illinois

Conditions: Peripheral T-cell Lymphoma
Interventions: Belinostat; Drug
Lead sponsor: Spectrum Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 42
States / cities: Duarte, California • La Verne, California • Palm Springs, California + 33 more

Conditions: Exocrine Pancreatic Insufficiency (EPI)
Interventions: Pancrelipase, Placebo; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 21 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 33
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fresno, California + 27 more

Conditions: Schwannoma, Vestibular, Neurofibromatosis 2, Meningioma
Interventions: Not listed
Lead sponsor: House Ear Institute; Other
Eligibility: 5 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Prodromal Schizophrenia, Psychosis, Psychological Disorder, Psychological Stress
Interventions: Health Behaviors Group; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 13 Years to 17 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Retinopathy, Diabetic Macular Edema
Interventions: Home vision monitoring using myVisionTrack®; Device
Lead sponsor: Vital Art and Science Incorporated; Industry
Eligibility: 40 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Anorexia Nervosa
Interventions: RhIGF-1 with transdermal 17-beta estradiol, Placebo and transdermal 17-beta estradiol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 22 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fluid Balance, Input and Output, Inflammatory Mediators, Acute Kidney Injury, Mortality
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cystitis, Interstitial
Interventions: AGN 203818; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Breast Cancer
Interventions: Taxotere; Drug
Lead sponsor: Baylor Breast Care Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tinnitus
Interventions: Tele-PTM, Wait List Control; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes Type 2
Interventions: Lifestyle and Activities Education Program (LEAP-AHEAD), Computer Automated Self-Management (CASM), Computer Automated Self-Management and Problem Solving Therapy (CAPS); Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 75 Years
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
Interventions: Atumelnant, Placebo; Drug
Lead sponsor: Crinetics Pharmaceuticals Inc.; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Chicago, Illinois + 8 more

Conditions: Gestational Diabetes
Interventions: Mobile health app called "Hola Bebe"; Behavioral
Lead sponsor: Environment and Health Group, Inc.; Industry
Eligibility: 19 Years to 45 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Search by objective public record fields.

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Trial of Combination Therapy to Treat COVID-19 Infection

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Anti-Diabetic Medications to Fight PD and LBD

Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure

A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump

Immuno-Oncology Database and Bioregistry

Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

NF2 Natural History Consortium

Feasibility Trial of a Lifestyle Intervention for CHR-P

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study

Effects of Anorexia Nervosa on Peak Bone Mass

Fluid Balance and Clinical Outcomes

Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

Neoadjuvant Taxotere

Telephone Tinnitus Education for Patients With Traumatic Brain Injury (TBI)

Reducing Distress and Improving Self-Care in Diabetes

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Mobile Health App to Reduce Diabetes in Latina Women